Ụdị Europe maka 3′-Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9

Quality First, and Client Supreme is our guideline to deliver the very best help to our shoppers.These days, we have been trying our great to be amongst the ideal exporters n'ime ubi anyị imezu ndị na-azụ ahịa mmezi ga mkpa maka Europe style maka 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, Site na mgbakwunye karịa afọ 8 nke obere azụmaahịa, anyị enwetala ahụmịhe bara ụba na teknụzụ dị elu n'oge nrụpụta ngwaahịa anyị.
Quality First, na Client Supreme bụ anyị ntuziaka na-anapụta ndị kasị mma aka anyị shoppers. Ndị a ụbọchị, anyị na-agbalị anyị kasị ukwuu na-n'etiti ezigbo eksporters n'ime anyị ubi imezu na-azụ ihe ọzọ ga-mkpa.China 77-92-9 na CAS 77-92-9, Dabere na anyị akpaka mmepụta akara, otu ebe ihe zuo ọwa na ngwa subcontract usoro e wuru na Chile China izute ahịa wider na elu chọrọ na-adịbeghị anya.Anyị na-atụ anya ka anyị na ọtụtụ ndị ahịa na-arụkọ ọrụ n'ụwa niile maka mmepe nkịtị na uru ọ bụla! Ntụkwasị obi na nkwenye gị bụ ụgwọ ọrụ kacha mma maka mbọ anyị.N'ịnọgide na-akwụwa aka ọtọ, ọhụrụ na ịrụ ọrụ nke ọma, anyị ji ezi obi na-atụ anya na anyị nwere ike ịbụ ndị mmekọ azụmahịa iji mepụta ọdịnihu anyị mara mma!

A na-eji 2′-hydroxy-3′-nitro-3-biphenylcarboxylic acid mee ihe dị ka etiti Eltrombopag.
Eltrombopag, nke GlaxoSmithKline (GSK) mepụtara na UK ma mechaa mebere ya na Novartis na Switzerland, bụ nke mbụ na naanị akwadoro obere molecule na-abụghị peptide TPO agonist n'ụwa.Ndị US FDA kwadoro Eltrombopag na 2008 maka ọgwụgwọ nke idiopathic thrombocytopenic purpura (ITP), na 2014 maka ọgwụgwọ nke anaemia siri ike (AA).Ọ bụkwa ọgwụ izizi nke US FDA kwadoro maka ọgwụgwọ AA n'ime afọ 30 na-adịbeghị anya.
Na december2012, US FDA kwadoro Eltrombopag maka ọgwụgwọ thrombocytopenia na-arịa ọrịa ịba ọcha n'anya C (CHC), nke mere na ndị ọrịa ịba ọcha n'anya C na-arịa ọrịa na-adịghị mma n'ihi ọnụ ọgụgụ platelet dị ala nwere ike ịmalite ma nọgide na-enwe usoro ọgwụgwọ interferon dabeere na ọgwụgwọ maka ọrịa imeju.Na Febụwarị 3,2014, GlaxoSmithKline kwupụtara na FDA nyere ntozu ọgwụgwọ ọgwụgwọ ọgwụgwọ Eltrombopag maka ọgwụgwọ hemopenia na ndị ọrịa nwere nnukwu akwụkwọ kemịkal aplastic anaemia (SAA) bụ ndị na-anabataghị nke ọma na immunotherapy.Na August 24, 2015, US FDA kwadoro Eltrombopag maka ọgwụgwọ thrombocytopenia na ndị okenye na ụmụaka dị afọ 1 na karịa na-adịghị ala ala thrombocytopenia (ITP) ndị na-enweghị nzaghachi zuru oke na corticosteroids, immunoglobulins ma ọ bụ splenectomy.Na Jenụwarị 4, 2018, a kwadoro Eltrombopag ka edepụta ya na China maka ọgwụgwọ nke thrombocytopenia nke mbụ na-alụso ọrịa ọgụ (ITP).

Quality First, and Client Supreme is our guideline to deliver the very best help to our shoppers.These days, we have been trying our great to be amongst the ideal exporters n'ime ubi anyị imezu ndị na-azụ ahịa mmezi ga mkpa maka Europe style maka 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, Site na mgbakwunye karịa afọ 8 nke obere azụmaahịa, anyị enwetala ahụmịhe bara ụba na teknụzụ dị elu n'oge nrụpụta ngwaahịa anyị.
Ụdị Europe makaChina 77-92-9 na CAS 77-92-9, Dabere na anyị akpaka mmepụta akara, otu ebe ihe zuo ọwa na ngwa subcontract usoro e wuru na Chile China izute ahịa wider na elu chọrọ na-adịbeghị anya.Anyị na-atụ anya ka anyị na ọtụtụ ndị ahịa na-arụkọ ọrụ n'ụwa niile maka mmepe nkịtị na uru ọ bụla! Ntụkwasị obi na nkwenye gị bụ ụgwọ ọrụ kacha mma maka mbọ anyị.N'ịnọgide na-akwụwa aka ọtọ, ọhụrụ na ịrụ ọrụ nke ọma, anyị ji ezi obi na-atụ anya na anyị nwere ike ịbụ ndị mmekọ azụmahịa iji mepụta ọdịnihu anyị mara mma!